MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - RANBAXY LABORATORIES

Ranbaxy Laboratories

BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 21, 17:00
436.35
-7.80 (-1.76%)
VOLUME 164,657
AVERAGE VOLUME
5-Day 184,188
10-Day 181,901
30-Day 112,682
VOLUME SHOCKER
5-Day 184,188
10-Day 181,901
30-Day 112,682
Prev. Close
444.15
Open Price
442.10
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
436.35 (300)
Today’s Low/High 433.00 442.10
52 Wk Low/High 370.50 578.30
LIVE
NSE
May 21, 17:00
436.35
-7.25 (-1.63%)
VOLUME 1,467,520
AVERAGE VOLUME
5-Day 1,476,749
10-Day 1,298,115
30-Day 845,650
VOLUME SHOCKER
5-Day 1,476,749
10-Day 1,298,115
30-Day 845,650
Prev. Close
443.60
Open Price
441.80
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
436.35 (833)
Today’s Low/High 432.25 441.80
52 Wk Low/High 370.80 578.40
Action in Ranbaxy Laboratories
MARKET CAP (Rs Cr)
18,462.01
*P/E
-
*BOOK VALUE (Rs)
45.40
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
28.10
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
9.61
DIV YIELD.(%)
-%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
27.72 new
DELIVERY AVERAGES
3-Day 38.39%
5-Day 35.10%
8-Day 31.67%
* Based on standalone numbers
Track Ranbaxy Labs on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Ranbaxy Labs today?
Test your strategy with virtual money on Moneybhai
F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 486.40 442.10  
High Price 496.00 442.10  
Low Price 485.00 433.00  
Last Price 490.25 436.35 -10.99
Volume 49,903 164,657 229.95
Simple Moving Averages
Days BSE NSE
30 450.66 450.94
50 442.90 443.12
150 473.49 473.67
200 487.88 488.07

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Dec '12)
Yearly
Net Sales 1381.64 6303.54
Other Income 52.33 239.60
PBDIT 84.21 700.08
Net Profit 70.15 -162.34
Balance Sheet
(Dec '12)
(In Rs Cr)
Total Share Capital 211.46
Net Worth 1922.08
Total Debt 4763.61
Net Block 1993.53
Investments 3131.17
Net Current Assets 1401.38
Total Assets 6685.68
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 973.65 0.78 997.95 569.00 100,829.44
Lupin 768.85 0.10 810.80 519.00 34,416.58
Dr Reddys Labs 2019.40 -1.37 2150.90 1555.00 34,296.78
Cipla 417.10 -0.07 435.00 305.00 33,489.85
GlaxoSmithKline 2275.90 -0.23 2522.00 2005.00 19,277.56
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Sep' 12Jun' 12
Promoter63.5263.5463.6463.66
FII10.5510.6510.579.66
DII10.0310.3910.6311.08
Others15.9015.4215.1615.60
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar
City
Mohali
State
Punjab
Pin Code
160071
Tel. No.
0172-6678666
Fax No.
0172-5013376
REGISTRARS
Name
Alankit Assignment Ltd.
Address
2E/8, Blazeflash House, R T A Division, 1st Floor Jhandewalan Extension,
City
New Delhi - 110055
State
Delhi
Tel. No.
011-51540060, 51540061, 51540062, 51540063
Fax No.
011-51540064
Internet
MANAGEMENT
Name
Designation
Tsutomu Une
Chairman
Arun Sawhney
Managing Director & CEO
Akihiro Watanabe
Director
Anthony H Wild
Director
Kazunori Hirokawa
Additional Director
Message Board & Community
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.